Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Trends Neurosci. 2020 Apr 17;43(6):433–449. doi: 10.1016/j.tins.2020.03.012

Table 1.

Technical Challenges for Discerning MNP Lineages in Retinal Degeneration.

Tools Pros Cons Refs
Marker staining
Conventional markers, such as Iba-1, F4/80, Cd11b
  • Labels the majority of MNPs

  • Unable to distinguish microglia and MdCs

  • Some markers not specific for MNPs

[2]
Microglial specific markers, such as P2ry12, Tmem119
  • Able to label specifically label microglia in steady state

  • May not distinguish microglia versus MdCs during neuroinflammation

[3,92,95]
Chimaeras
Bone marrow chimera
  • Full blood chimerism

  • Side effects of irradiation and transplantation, such as temporary disruption of BRB and myelomonocytic engraftment in the CNS

[2]
Bone marrow chimera with lead head shielding
  • Preservation of CNS in steady state

  • Full blood chimerism is not achievable

[11]
Circulating monocyte-labeling
Systemic 5- ethynyl-2′- deoxyuridine (EdU)
  • A traceable nucleotide that is integrated into the DNA of dividing cells

  • Efficient labeling short-lived circulating monocytes and MdCs but not long-lived microglia in steady state.

  • Nuclear stain, avoids confounding with (i) MNP auto-fluorescence and (ii) positivity due to transfer (phagocytosis) of reporter proteins

  • Require repeated injections, which limits use for short-term study but not chronic conditions.

  • Microglia may replicate during degeneration, local injections necessary for distinction

[6]
Intravenously injected fluorescent tracers
  • A traceable fluorescent probe taken up by circulating monocytes and detectable in cells derived from these monocytes.

  • Require repeated injections, which limits it for short-term study but not chronic conditions.

[72]
Reporter mice
Cx3cr1GFP or Cx3cr1YFP
  • Heterozygotes are good for labeling MNPs

  • Homozygotes are a full deletion of Cx3cr1 gene

  • Unable to distinguish microglia and MdCs, as both express Cx3cr1

[11,14,105]
Ccr2RFP
  • Heterozygotes are good for labeling classical monocytes

  • Homozygotes are a full deletion of Ccr2 gene

  • Not good for labeling monocyte-derived macrophages, which lose Ccr2 expression

  • Spares non-classical monocytes

[6,7,34]
Cx3cr1CreER R26fl-STOP-fl-reporter
  • Tamoxifen treatment induces the expression of reporter and labels microglia and MdCs

  • The reporter expression in monocytes is ‘washed out’, as they are quickly replaced by non-labeled cells once tamoxifen decayed

  • Other long-lived tissue-resident macrophages that maintain Cx3cr1 expression may also be labeled

[9,11,34,84,85]
Depletion / recruitment inhibition studies
Csf1r antagonists
  • Efficient depletion of Csf1r dependent macrophages

  • Easy for administration

  • Indistinguishably ablate microglia and MdCs

  • Potential off-target effects on other tyrosine kinase receptors

[97,98,127]
Intravenous clodronate liposome
  • Efficient depletion of monocytes and their derivatives

  • Require repeated injections, which limits it for short-term study but not chronic conditions.

  • Potential off-target effects

[6,98]
Cx3cr1CreER R26fl-STOP-fl-DTA
  • Efficient depletion of MNPs

  • Not require diphtheria toxin

  • Indistinguishably depletes all Cx3cr1 expressing MNPs

  • Require multiple tamoxifen administrations

[37,113]
Cx3cr1CreER R26fl-STOP-fl-DTR
  • Efficient depletion of microglia following ‘washout’

  • Require tamoxifen and diphtheria toxin administration

  • Other long-lived tissue-resident macrophages may also be depleted

[3,84]
Ccl2- and Ccr2- deletion / inhibition
  • Efficiently inhibits exit of bone marrow classical monocyte into the blood

  • Does not inhibit non-classical monocyte-recruitment

[67, 7380]